Supriya Lifescience Reports Record Q3 FY24-25 Results, Highlighting Strong Growth Metrics

Jan 24 2025 05:49 PM IST
share
Share Via
Supriya Lifescience has announced its financial results for Q3 FY24-25, highlighting significant growth in net sales, operating profit, and profitability metrics. The company achieved record net sales of Rs 185.65 crore and reported its highest profit levels in five quarters, reflecting a strong market position and operational efficiency.
Supriya Lifescience has recently reported its financial results for the third quarter of FY24-25, showcasing notable developments in its performance within the pharmaceuticals and drugs sector. The company announced its results on January 24, 2025, revealing significant advancements in various financial metrics.

Net sales achieved an all-time high of Rs 185.65 crore, demonstrating consistent growth over the past five quarters. This trend underscores the company's strong market presence and effective sales strategies. Operating profit also experienced a noteworthy rise, with PBDIT reaching Rs 65.95 crore, highlighting operational efficiency.

Profit before tax (PBT) was reported at Rs 60.48 crore, while profit after tax (PAT) amounted to Rs 46.78 crore, both marking the highest levels in the last five quarters. This sustained growth in profitability reflects Supriya Lifescience's solid financial foundation.

Furthermore, the earnings per share (EPS) reached Rs 5.81, indicating enhanced profitability and value for shareholders. Overall, Supriya Lifescience's latest financial results illustrate a favorable trajectory, reinforcing its standing in the midcap pharmaceutical industry.

Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News